Please assess the completion status of the following clinical trial:

Trial Title: Oxytocin in Adolescents With Autism Spectrum Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male~* Age between 11 years 11 months and 17 years 11 months~* Autism spectrum disorder according to DSM V~* ADI \> 10~* WISC \> 70~* CARS \> 30~Exclusion Criteria:~* Female~* presence of genetic and neurological syndromes~* changes in drugs or in any intervention during the study

- Gender: MALE
- Minimum Age: 12 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- OCYTOCINA - SPRAY NASAL (Type: ACTIVE_COMPARATOR): OCYTOCINA - SPRAY NASAL - 24Ui twice per day for 8 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Placebo - twice per day for 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).